OrganOx completed a $142 million primary and secondary equity financing led by HealthQuest Capital, joined by BGF and Lauxera Capital Partners

Health services Manufacturing

Investments

14 February 2025

OrganOx (company)

Health services Manufacturing

Total investments received (USD): N/A

Round value (USD): 142m

Round investors: BGF Lauxera Capital Partners Longwall Ventures Oxford Science Enterprises Oxford Technology and Innovations EIS Fund Sofina Soleus Capital Management HealthQuest Capital Avidity Partners Technikos

Company: OrganOx

Industry: Health services Manufacturing

Health services Manufacturing

Secondary 14 July 2025

Biotech Health services Manufacturing

Investments 07 June 2025

Biotech Health services Manufacturing

Investments 09 May 2025

Biotech Health services Manufacturing Pharma

Investments 10 December 2024